| mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.14 |
0.0004 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
| mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.001 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
| mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.005 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.008 |
| mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.009 |
| mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.01 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
| mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.11 |
0.01 |